Intuitive Surgical, Inc. $ISRG Stock: WD Rutherford LLC Lowers Position

WD Rutherford LLC reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 54.5% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 1,056 shares of the medical equipment provider’s stock after selling 1,266 shares during the quarter. WD Rutherford LLC’s holdings in Intuitive Surgical were worth $429,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Main Street Group LTD purchased a new stake in shares of Intuitive Surgical during the 1st quarter worth about $30,000. North Point Portfolio Managers Corp OH bought a new stake in shares of Intuitive Surgical in the 3rd quarter valued at approximately $27,000. Compass Wealth Management LLC bought a new stake in shares of Intuitive Surgical in the 3rd quarter valued at approximately $29,000. Evergreen Advisors LLC bought a new stake in shares of Intuitive Surgical in the 1st quarter valued at approximately $35,000. Finally, Compass Financial Management LLC acquired a new position in Intuitive Surgical in the second quarter worth approximately $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, VP Fredrik Widman sold 4,047 shares of the business’s stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $453.21, for a total transaction of $1,834,140.87. Following the completion of the transaction, the vice president owned 1,026 shares of the company’s stock, valued at approximately $464,993.46. The trade was a 79.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Craig Barratt sold 1,150 shares of the business’s stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $443.80, for a total value of $510,370.00. Following the transaction, the director directly owned 1,150 shares of the company’s stock, valued at $510,370. This represents a 50.00% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 38,684 shares of company stock valued at $16,770,301 in the last ninety days. Company insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on ISRG shares. BTIG Research reaffirmed a “buy” rating and set a $454.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 21st. BMO Capital Markets reiterated an “outperform” rating on shares of Intuitive Surgical in a research note on Monday, July 20th. Royal Bank Of Canada decreased their target price on shares of Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating for the company in a research report on Wednesday, October 21st. Oppenheimer restated an “outperform” rating and set a $500.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Finally, Truist Financial dropped their price target on shares of Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a research note on Thursday, July 16th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $493.54.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Wall Street remains broadly constructive: the average brokerage recommendation is equivalent to a Buy, while the reported consensus price target of $493.54 is above recent trading levels. However, the article cautions that sell-side ratings can be overly optimistic. Wall Street bullish views on ISRG
• Positive Sentiment: Analysts have been raising earnings estimates, and Zacks highlighted ISRG’s growth profile. The company’s latest quarterly results provide fundamental support, with revenue up 21.7% year over year to $3.05 billion and earnings of $3.00 per share versus a $2.65 consensus estimate. Higher earnings estimates
• Neutral Sentiment: ISRG is attracting substantial investor attention, which may increase trading activity but does not necessarily signal a change in business fundamentals. Reported short interest of zero shares and a zero-day days-to-cover ratio also appear inconsistent with the description of a significant increase, limiting the data’s usefulness. ISRG trending-stock analysis
• Negative Sentiment: Several insiders sold shares under pre-arranged Rule 10b5-1 plans. Director Gary Guthart sold approximately $9.1 million, while a vice president, senior vice president and another director also reduced their holdings. Although planned sales are not necessarily bearish, the cluster may weigh on sentiment. ISRG insider selling
• Negative Sentiment: Valuation remains a key risk. ISRG trades at roughly 54 times earnings and a PEG ratio above 3, leaving limited room for execution disappointments. The stock’s decline below its 200-day moving average may also indicate near-term technical weakness.

Intuitive Surgical Trading Down 1.3%

Shares of ISRG opened at $445.88 on Wednesday. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88. The company’s fifty day moving average price is $398.31 and its 200 day moving average price is $436.15.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter last year, the company earned $2.40 earnings per share. The firm’s revenue was up 21.7% on a year-over-year basis. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.